A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain medication that’s just been approved by the FDA. Suzetrigine is the first ...

Given the increased use — and misuse — of opioid medications, it is imperative that we continue to expand access to drug-free pain treatment options that can effectively address the underlying cause ...

Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

A new drug is providing hope for patients with severe or moderate acute pain, offering an alternative that is designed to be less harmful than opioids. The drug, called Journavx, is part of a broader ...

Joint pain can be caused by a number of biological, psychological, and social factors. The most common cause of joint pain is different types of arthritis. There is a wide availability of medications ...

The Gulf Pain Management Drugs Market was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%. Rise in geriatric population is the major ...

A tool that uses artificial intelligence to pinpoint the delivery of pain management drugs to an injury site is being developed by Army researchers. The aim is to allow personnel who may have limited ...